165 related articles for article (PubMed ID: 34230442)
21. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
[TBL] [Abstract][Full Text] [Related]
22. TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.
Schwartz FH; Cai Q; Fellmann E; Hartmann S; Mäyränpää MI; Karjalainen-Lindsberg ML; Sundström C; Scholtysik R; Hansmann ML; Küppers R
J Pathol; 2017 Jun; 242(2):129-133. PubMed ID: 28337768
[TBL] [Abstract][Full Text] [Related]
23. Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.
Saillard C; Guermouche H; Derrieux C; Bruneau J; Frenzel L; Couronne L; Asnafi V; Macintyre E; Trinquand A; Lhermitte L; Molina T; Suarez F; Lemonnier F; Kosmider O; Delarue R; Hermine O; Cheminant M
Hematol Oncol; 2017 Dec; 35(4):864-868. PubMed ID: 27353473
[TBL] [Abstract][Full Text] [Related]
24. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
[TBL] [Abstract][Full Text] [Related]
25. Angioimmunoblastic T-Cell Lymphoma.
Yabe M; Dogan A; Horwitz SM; Moskowitz AJ
Cancer Treat Res; 2019; 176():99-126. PubMed ID: 30596215
[TBL] [Abstract][Full Text] [Related]
26. Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene.
Liang PI; Chang ST; Lin MY; Hsieh YC; Chu PY; Chen CJ; Lin KJ; Jung YC; Hwang WS; Huang WT; Chang WC; Ye H; Chuang SS
Int J Clin Exp Pathol; 2014; 7(9):6097-107. PubMed ID: 25337257
[TBL] [Abstract][Full Text] [Related]
27. Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis.
Ren Y; Gu Y; Wang W; Wang J; Li X; Wang Y; Gao H; Dong X; Tian Y
Cell Cycle; 2016 Jun; 15(12):1545-51. PubMed ID: 27124741
[TBL] [Abstract][Full Text] [Related]
28. Advances in the pathogenesis and therapeutic strategies of angioimmunoblastic T-cell lymphoma.
Zhang Q; Yin L; Lai Q; Zhao Y; Peng H
Clin Exp Med; 2023 Dec; 23(8):4219-4235. PubMed ID: 37759042
[TBL] [Abstract][Full Text] [Related]
29. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
[TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
[TBL] [Abstract][Full Text] [Related]
31. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.
Lunning MA; Vose JM
Blood; 2017 Mar; 129(9):1095-1102. PubMed ID: 28115369
[TBL] [Abstract][Full Text] [Related]
32. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
[TBL] [Abstract][Full Text] [Related]
33. GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism.
Mondragón L; Mhaidly R; De Donatis GM; Tosolini M; Dao P; Martin AR; Pons C; Chiche J; Jacquin M; Imbert V; Proïcs E; Boyer L; Doye A; Luciano F; Neels JG; Coutant F; Fabien N; Sormani L; Rubio-Patiño C; Bossowski JP; Muller F; Marchetti S; Villa E; Peyron JF; Gaulard P; Lemonnier F; Asnafi V; Genestier L; Benhida R; Fournié JJ; Passeron T; Ricci JE; Verhoeyen E
Cancer Cell; 2019 Sep; 36(3):268-287.e10. PubMed ID: 31447347
[TBL] [Abstract][Full Text] [Related]
34. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.
Cairns RA; Iqbal J; Lemonnier F; Kucuk C; de Leval L; Jais JP; Parrens M; Martin A; Xerri L; Brousset P; Chan LC; Chan WC; Gaulard P; Mak TW
Blood; 2012 Feb; 119(8):1901-3. PubMed ID: 22215888
[TBL] [Abstract][Full Text] [Related]
35. Inappropriate costimulation and aberrant DNA methylation as therapeutic targets in angioimmunoblastic T-cell lymphoma.
Willemsen M; Schouten HC
Biomark Res; 2017; 5():6. PubMed ID: 28194275
[TBL] [Abstract][Full Text] [Related]
36. Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma.
Yoon SE; Cho J; Kim YJ; Kim SJ; Kim WS
Clin Lymphoma Myeloma Leuk; 2022 Nov; 22(11):e972-e980. PubMed ID: 35995702
[TBL] [Abstract][Full Text] [Related]
37. Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
Zhang C; Mou B; Xu J; Wang J; Liu Q; Yang Y; Tang W; Zhong X; Xu C
Br J Haematol; 2023 Dec; 203(5):807-819. PubMed ID: 37646306
[TBL] [Abstract][Full Text] [Related]
38. Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics.
Attygalle AD; Chuang SS; Diss TC; Du MQ; Isaacson PG; Dogan A
Histopathology; 2007 Mar; 50(4):498-508. PubMed ID: 17448026
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and treatment of angioimmunoblastic T-cell lymphoma and related cancers].
Sakata-Yanagimoto M
Rinsho Ketsueki; 2019; 60(9):1221-1228. PubMed ID: 31597847
[TBL] [Abstract][Full Text] [Related]
40. Spatial Transcriptomics Analysis Reveals that CCL17 and CCL22 are Robust Indicators of a Suppressive Immune Environment in Angioimmunoblastic T Cell Lymphoma (AITL).
Du J; Qiu C; Li WS; Wang B; Han XL; Lin SW; Fu XH; Hou J; Huang ZF
Front Biosci (Landmark Ed); 2022 Sep; 27(9):270. PubMed ID: 36224014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
